ACCOUNT RESEARCH FOR STEM-CELL AND REGENERATIVE-MEDICINE EDUCATION PROGRAMS SELLERS

Put education on the agenda—not treatment promises.

For legitimate stem-cell and regenerative-medicine provider teams: plan an education-first dinner and a clearly optional onsite appointment-request path. Keep clinical evaluation independent, protect attendee privacy, and budget the event without forecasting treatment revenue.

Find my buyers Plan the event costs

The accounts. The business case. The next move.

For legitimate provider teams. Dinner attendance is not clinical eligibility or informed consent. Voluntary follow-up requires independent clinical review; no patient health-data collection. FDA warns about unapproved regenerative products. No treatment benefit, cure, safety or approval claim is implied.

ILLUSTRATIVE EDUCATION / REVIEW PATH, NOT APPOINTMENT ACTIVITY
  1. 01Education dinner
  2. 02Optional onsite follow-up
  3. 03Event budget
  4. 04Evidence → account report
Fit is a hypothesis.
Evidence supports the next move.
01 / NEXTA plausible account is only the start.

THE PAIN / NOT ANOTHER GENERIC LIST

The risk isn't dinner. It's blurred lines.

Before selling time becomes sunk time, test the obstacles.

Education can sound like an outcome claim

Regenerative medicine is often marketed with claims that FDA says may mislead; event content needs careful, product-specific review.

A dinner is not a clinical pathway

Separate general education from diagnosis, eligibility decisions, informed consent, and any independent clinical evaluation.

Follow-up must stay voluntary

An onsite option can invite requests without pressure, collecting health details, or implying that attendance means eligibility.

02 / NEXTThe obstacle becomes a research question.

WHAT ALMA HUNTER DELIVERS

Make the next step clear—and voluntary.

  1. 01

    An education-first event

    Give provider teams a clear agenda for explaining evidence, uncertainty, and product-specific regulatory status without promising outcomes.

  2. 02

    A respectful onsite path

    Offer attendees an optional way to request a separate appointment; clinical teams determine whether evaluation is appropriate.

  3. 03

    A grounded event budget

    Plan fixed costs, extra operating costs, attendee count, and variable per-attendee spend—without treatment-revenue assumptions.

FROM PROFILE TO A SUPPORTED NEXT MOVE
ALMA HUNTER / ACCOUNT REPORT
01Program fitEvidence + unknowns
02Event costsNot patient ROI
03Clinical reviewEvidence + unknowns
04Voluntary interestEvidence + unknowns
05TimingEvidence + unknowns
06Decision rolesEvidence + unknowns
BANTBudget · Authority · Need · Timing
BUDGET UNKNOWNHOLD / VALIDATE

Illustrative qualification, not a researched account. Unknowns stay unknown.

03 / NEXTA better-supported account gives your team something to measure.

THE KPIs / TRACK, DO NOT PROMISE

Better evidence.
Clearer sales decisions.

Metrics to monitor—not guaranteed lifts, meetings or sales.

TRACK 01

Learning objectives covered

Set a target for the share of planned educational topics delivered; verify against the event agenda afterward.

TRACK 02

Attendee understanding check

Set an aggregate learning target and use an optional, non-health-related knowledge check; do not treat it as clinical screening.

TRACK 03

Voluntary follow-up requests

Set a count target for attendees who independently request follow-up; it is not an appointment, eligibility, or conversion forecast.

04 / NEXTEvent costs and clinical decisions are separate questions.

PROGRAM OPERATIONS / NOT PATIENT PROFIT

Plan the dinner.
Leave medicine to clinical review.

This is an education-event cost planner—not patient ROI, treatment revenue, medical benefit or a booked-appointment forecast.

EVENT COSTS / FICTIONAL PLANNING INPUTS

Plan the event. Do not price a medical outcome.
Venue, setup and fixed program costs; do not include them again below.
Staffing or other fixed costs not already included above.
A planning assumption, not actual attendance, clinical eligibility or appointments.
Catering and other per-person costs, counted once.

USD / EVENT BUDGET, NOT PATIENT ROI

$5,250Total modeled event cost
Fixed costs$3,000
Variable attendee costs$2,250
Cost per planned attendee
$175

An invitation is not informed consent. An appointment is not clinical eligibility.

No treatment revenue, booked-appointment rate, medical benefit or treatment outcome is modeled.

Keep the boundaries clear.

Fictional event planning only. Total cost = fixed event costs + additional fixed costs + planned attendees × variable cost per attendee. Each cost is counted once; these are not quotes. No actual attendance, clinical eligibility, treatment revenue, patient ROI, evaluation conversion or medical outcome is forecast.

See budget formula, required evidence and clinical context

Total event cost = fixed event costs + additional fixed costs + planned attendees × variable cost per attendee. Cost per attendee = total ÷ planned attendees. Each cost is counted once.

Replace illustrative inputs with approved event estimates and actual invoices: fixed venue/program costs, extra operating costs, planned attendees, and variable cost per attendee. Compare the planned budget with event spend; do not infer clinical or commercial outcomes.

Provider/program inquiries only. Do not submit patient medical information. Treatment-specific claims require appropriate regulatory and independent clinical review.

FROM THE FOUNDER / NOT A CUSTOMER TESTIMONIAL

Built from the seller’s side.

“Finding companies was never the hard part.”

Scott Hawkyard · Founder, Alma Hunter

A buyer needs a supported business case—not another profile match.

THE NEXT MOVE

Find the buyers.
Bring the case.

Tell us what you sell and who buys it. We agree scope, price and delivery before payment. An inquiry does not start research.

Find my buyers
ALMA HUNTER / YOUR ACCOUNT REPORT
Program fit.Evidence.Your next move.

Accounts reviewed against your brief.
Unknowns left visible.